Delivery Order SPE2DB25D2204-SPE2DB25FTGWS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,606.41. This is a firm fixed-price delivery order with no set-aside designation, executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100-count units) with a ceiling value of $1,036.54. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a $2,891.34 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dexmethylphenidate ER 15 mg capsules (100 count). The contract is firm fixed price with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child delivery order under a larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,143.20 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 25 mg capsules (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This competitive, non-set-aside delivery order utilizes firm fixed price terms and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for dexmethylphenidate ER 25 mg capsules (100-count) on August 20, 2025, with a ceiling value of $1,011.21. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order, which is structured as a child contract under a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a ceiling value of $1,550.88. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a ceiling value of $1,819.43. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a ceiling value of $1,148.65. This non-competitive, firm fixed-price delivery order is set to conclude on September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's existing...
- The Defense Logistics Agency awarded a $1,048.50 delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 20 mg capsules (100 count) on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price contract represents a non-set-aside competitive award and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,148.12 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 30 mg capsules (100 count) with an ultimate completion date of July 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTGWSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,656.97 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100 count). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The order is scheduled for ultimate completion by August 18, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's contract portfolio with DLA demonstrates its capacity to supply a broad range of pharmaceutical products across multiple therapeutic domains on a competitive basis. This specific delivery order for a neurological medication reflects the company's ongoing role in supporting Defense Health Agency and other federal healthcare systems through flexible contract vehicles designed to meet diverse medical supply requirements across global operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/15/25 |